Literature DB >> 6386894

Active site directed inhibitor used in the production of antibodies against urokinase.

S A Cederholm-Williams, J M Marshall, H Chissic.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6386894      PMCID： PMC498967          DOI： 10.1136/jcp.37.10.1193

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

1.  Fibrinolysis associated with oncogenic transformation. Morphological correlates.

Authors:  L Ossowski; J P Quigley; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

2.  Molecular mechanism of fibrinolysis--a system involved with malignant cells.

Authors:  S A Cederholm-Williams
Journal:  Invasion Metastasis       Date:  1981

3.  Radioimmunoassay of urokinase for quantification of plasminogen activators released in ovarian tumour cultures.

Authors:  B Astedt; L Holmberg; I Lecander; J Thorell
Journal:  Eur J Cancer       Date:  1981-02       Impact factor: 9.162

4.  Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone.

Authors:  P Coleman; C Kettner; E Shaw
Journal:  Biochim Biophys Acta       Date:  1979-07-11

5.  Purification and partial characterization of plasminogen activator from human uterine tissue.

Authors:  D C Rijken; G Wijngaards; M Zaal-de Jong; J Welbergen
Journal:  Biochim Biophys Acta       Date:  1979-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.